GlassScriptPhysician profile
Spencer Melby
NPI 1720081243
$29,644.40
in general payments reported to CMS, 2019-2025
24 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,260 · 2020: $15K · 2021: $288 · 2022: $4,956 · 2023: $205 · 2024: $274 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701 · Travel and Lodging: $28.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.12 |
| Travel and Lodging | $28.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clearflow INC. | $25,885.98 | 2019-2022 | |
| Livanova USA, INC. | $1,348.44 | 2019 | |
| Edwards Lifesciences Corporation | $755.48 | 2019-2022 | |
| Artivion, INC. | $448.91 | 2019-2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Medtronic Vascular, INC. | $233.83 | 2019-2020 | |
| Atricure, INC. | $200.50 | 2020-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Depuy Synthes Sales INC. | $161.43 | 2024-2025 | Matrixrib, Trumatch |
| Bolton Medical INC | $112.70 | 2025 | Thoraflex Hybrid |
| Getinge USA Sales, LLC | $87.23 | 2023-2024 | Vasoview Hemopro 2 |
| Veran Medical Technologies, INC. | $85.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $59.01 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $43.46 | 2023 | Sternalock Blu System |
| Merck Sharp & Dohme LLC | $32.03 | 2023-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $29.49 | 2023 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $28.76 | 2024 | Xarelto |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $28.40 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $24.36 | 2023 | Inpefa |
| Pfizer INC. | $19.65 | 2024 | |
| Amryt Pharma Holdings LTD | $18.62 | 2023 | Juxtapid |
| Boston Scientific Corporation | $15.72 | 2024 | Watchman Flx |
| Ethicon US, LLC | $15.45 | 2024 | Vistaseal, Ethicon, Monocryl |
| Quest Medical INC. | $9.73 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Melby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.